TrialTheranostics2015

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.

Feng-Qin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.